Bioventus Inc.
Status: Publicly traded
Direct answer
Bioventus Inc. is publicly traded on NASDAQ under the ticker BVS.
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to...
Can you invest in Bioventus Inc.?
Yes. Bioventus Inc. is publicly traded on NASDAQ under the ticker BVS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Bioventus Inc.
Detailed equity research is provided by MarketSnap.